Article
ACOX1 gain-of-function variation in a 10-years-old patient responsive to immunomodulating therapy.
American journal of medical genetics. Part A - 1 Nov 2024
Filippi Corinna, Brunetti Sara, Plumari Massimo, Valente Enza Maria, Accorsi Patrizia, Fazzi Elisa Maria
Abstract excerpt
A heterozygous gain-of-function variant in the acyl-CoA oxidase 1 (ACOX1) gene, c.710A>G (p.Asn237Ser), is known to cause Mitchell syndrome, a very rare progressive disorder characterized by episodic demyelination, sensory polyneuropathy, and hearing loss. Only eight patients have been described so far. A single patient has been treated with intravenous immunoglobulin administration, indicating clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
